EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31

Janya Grainok, Ianthe L Pitout, Fred K Chen iD, Samuel McLenachan, Rachael C Heath Jeffery, Chalermchai Mitrpant iD, Sue Fletcher iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Janya Grainok und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: RNA Precursors, Oligonucleotides, Antisense, Retinitis Pigmentosa. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Murdoch Strategic Scholarship, Australia and the Dual-PhD Program Scholarship, Mahidol University, Thailand, National Health and Medical Research Council, Siriraj Graduate Scholarship, Mahidol University, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinitis pigmentosa 11 is an untreatable, dominantly inherited retinal disease caused by heterozygous mutations in pre-mRNA processing factor 31 PRPF31. The expression level of PRPF31 is linked to incomplete penetrance in affected families; mutation carriers with higher PRPF31 expression can remain asymptomatic. The current study explores an antisense oligonucleotide exon skipping strategy to treat RP11 caused by truncating mutations within PRPF31 exon 12 since it does not appear to encode any domains essential for PRPF31 protein function. Cells derived from a patient carrying a PRPF31 1205C>A nonsense mutation were investigated; PRPF31 transcripts encoded by the 1205C>A allele were undetectable due to nonsense-mediated mRNA decay, resulting in a 46% reduction in PRPF31 mRNA, relative to healthy donor cells. Antisense oligonucleotide-induced skipping of exon 12 rescued the open reading frame with consequent 1.7-fold PRPF31 mRNA upregulation in the RP11 patient fibroblasts. The level of PRPF31 upregulation met the predicted therapeutic threshold of expression inferred in a non-penetrant carrier family member harbouring the same mutation. This study demonstrated increased PRPF31 expression and retention of the nuclear translocation capability for the induced PRPF31 isoform. Future studies should evaluate the function of the induced PRPF31 protein on pre-mRNA splicing in retinal cells to validate the therapeutic approach for amenable RP11-causing mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA PrecursorsOligonucleotides, AntisenseRetinitis PigmentosaHumansOpen Reading FramesMutationCodon, NonsenseEye ProteinsPedigree

Stichwörter der Autor:innen

antisense oligonucleotidesexon skippingprecision medicineretinitis pigmentosasplicing factor

Substanzen

RNA PrecursorsOligonucleotides, AntisenseCodon, NonsenseEye ProteinsPRPF31 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
  • Centre for Ophthalmology and Visual Science, University of Western Australia, Nedlands, WA 6009, Australia.
  • Lions Eye Institute, Nedlands, WA 6009, Australia.
  • Department of Ophthalmology, Royal Perth Hospital, Perth, WA 6000, Australia.
  • Department of Surgery, University of Melbourne, East Melbourne, VIC 3002, Australia.

ORCID-Profile: Fred K Chen, Chalermchai Mitrpant, Sue Fletcher

Förderung

  • Murdoch Strategic Scholarship, Australia and the Dual-PhD Program Scholarship, Mahidol University, Thailand
  • National Health and Medical Research Council
  • Siriraj Graduate Scholarship, Mahidol University, Thailand
  • Murdoch Strategic Scholarship, Murdoch University, Australia
  • Dual-PhD Program Scholarship, Mahidol University, Thailand
  • Future Health Research and Innovation Fund
  • WA Health
  • National Health & Medical Research Council of Australia

Zitieren

APA

Grainok, J., Pitout, I. L., Chen, F. K., McLenachan, S., Heath Jeffery, R. C., Mitrpant, C., & Fletcher, S. (2024). A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063391

Vancouver

Grainok J, Pitout IL, Chen FK, McLenachan S, Heath Jeffery RC, Mitrpant C, et al. A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063391

BibTeX
@article{Grainok2024,
  author = {Grainok, Janya and Pitout, Ianthe L and Chen, Fred K and McLenachan, Samuel and Heath Jeffery, Rachael C and Mitrpant, Chalermchai and Fletcher, Sue},
  title = {A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063391}
}
Kostenlos starten →